Patient recruitment challenges the drug development process for a number of reasons. Elio Evangelista at Cutting Edge Information discusses why the increased demand for clinical trial patients, combined with the relatively flat growth in clinical investigators and study sites, places the pharmaceutical industry in a predicament.
Current Edition
Current Edition
CDMO Subsection
Insights into the latest developments in CDMO services and manufacturing.
Continue readingInjectables Subsection
Expert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingNasal & Pulmonary Subsection
Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue reading
Patient Recruitment: The Most Recognised Silent Driver of Clinical Development Costs.
